Friday, November 20, 2026
Late edition · Updated as it breaks
Log inSubmit a story

“All the news worth catching.”

PaparazziPaparazzi
Top storiesBack PageHow to earnLeaderboard
Catcher tip lineCaught a story first? Earn stock tokens →
Sponsored
Premium projects
DEDeFadePAPackedYour project here
PaparazziPaparazzi

All the news worth catching.

Breaking news on tech, crypto, EVs, e-commerce and social the moment it breaks. Written by AI from verified reporting.

SectionsTop storiesRobinhood ChainTech & AIE-commerceWeb3 & CryptoEV & EnergyGlobal & SocialEntertainmentGamingSportsBusiness & marketsHealth & sciencePolitics & world
EarnStart hereSubmit a storyGTA WeekHow to earnLeaderboardContestsCatcher desksTop catchers by reputationAssignmentsLeagueNews bountiesCityMy catchesRewards
MarketsLive statsProof of payoutsWhale watchDeep Scan token checksStock fundHolder perksRobinhood Chain launchesRobinhood Chain projectsList your projectPremium project pagesPartnersThe Chain Weekly
PaparazziPaparazzi InkPaparazzi Ink top writersOpinionLive coverageEvents calendarThe Back PageSuggest a Back Page storyPaparazzi on TelegramHow it worksFAQProof of workAbout usHow we score trustEditorial policyPrivacy policyCorrectionsRelease notesAdvertiseMedia kitNews APIContact
$PAPA contract · Robinhood Chain
© 2026 Paparazzi

Written by AI from verified reporting. Not financial advice.

  • Home
  • Submit
  • Earn
  • Sign in
Top storiesRobinhood ChainTech & AIE-commerceWeb3 & CryptoEV & EnergyGlobal & SocialEntertainmentGamingSportsBusiness & marketsHealth & sciencePolitics & worldWhales
Tech & AI
Important· 51

OpenAI Builds MedChemBench to Grade AI on Early Drug Discovery

OpenAI rolled out MedChemBench, a benchmark that tests how well AI models read molecular structures, weigh experimental evidence and pick compounds worth pursuing. It's built from 117 papers and patents and 761 molecular structures, with GPT-6.2 Astra hitting 84.5%.

By the Paparazzi desk November 20, 2026 · 7:21 PM · blockchain.news · 0 views
Fact boxTrust 50/100 · Developing
What we verified
  • Original source: blockchain.news.
  • The source published it on Nov 20, 2026 at 7:21 PM.
What we couldn't
  • No second outlet has reported it yet. Treat it as a single-source claim.

MedChemBench is OpenAI's new yardstick for AI in early-stage drug discovery, per Blockchain.News. It checks whether models can interpret molecular structures, reason from experimental evidence and flag promising compounds for further testing. The benchmark leans on 117 scientific papers and patents covering 761 distinct molecular structures, and it breaks evaluation into four components.

The problems are drawn from real research: 99 tasks that mimic what medicinal chemists actually face. Models have to link molecular changes to experimental outcomes and reason through trade-offs between properties like efficacy, absorption and stability. GPT-6.2 Astra scored 84.5% overall, standing out at reconstructing molecular structures and explaining experimental evidence, though picking compounds and predicting numerical properties tripped it up.

Sponsored

That trade-off problem is the hard part. A compound might hit a disease-related protein hard yet absorb poorly or break down quickly in the body. MedChemBench feeds models context from ongoing research programs, including biological targets, experimental findings and prior compound studies, to see how they handle those competing demands.

OpenAI frames the benchmark as groundwork for AI tools scientists can actually lean on when developing medicines. It lands amid a wider pharmaceutical push to use AI to speed up drug discovery and cut costs and wasted experiments.

TopicsOpenAI · MedChemBench · GPT-6.2 Astra

Share

Source: blockchain.news

Written by AI from verified reporting.

More stories

  • Tech & AI 20:31 UTC · 20 minutes ago · techcrunch.com · 1 view
    Two Riemann proofs drop in one week: one built with Claude, one all human
  • Tech & AI 20:30 UTC · 20 minutes ago · cryptobriefing.com · 1 view
    Report: Nvidia loses $2.8T in market value over 33 days after CEO exit
  • Tech & AI 20:16 UTC · 35 minutes ago · cryptobriefing.com 3 sources· 1 view
    S&P 500 Falls Below 7,000 as SEC Reportedly Probes Nvidia
  • Tech & AI 20:01 UTC · 50 minutes ago · x.com 3 sources· 0 views
    SEC opens probe into Nvidia over accounting questions, stock tanks
Catcher tip line

Caught a story we missed?

Log in and send it in. If it checks out, it runs with your name on it and you earn stock tokens. The bigger the story, the bigger the reward.

Submit a story
The newsletter

Get the paper in your inbox.

A short digest of the biggest news, plus optional breaking alerts. Free, no account needed.